Diabetes Care Devices and Drugs Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices and Insulin delivery devices), By End use(Hospitals, Ambulatory surgery centres, Diagnostic centres, Home care), By Region - Industry Forecast 2025-2032

Based on region, global diabetes care devices and drugs market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global market in 2022. According to world health organization, In North America, there are more than 29 million diabetic patients and this number is expected to increase to 34 million by 2027. The increase in number of diabetes patients in Europe, lower prices of insulin and insulin delivery devices, increasing demand and sale of insulin delivery devices are the key factors driving the growth of global market.

Asia Pacific is the fastest growing region in the global diabetes care devices market due to increasing diabetic population, government initiatives to increase awareness about self-diabetes management, and increasing technological advancements in the region. According to Down to Earth, on December 6, 2021, the estimated number of diabetic patients aged 20-79 in 2021 is 74.2 million and is expected to increase to 124.8 million in 2045 in India. China accounted for the largest revenue share in the global market in 2022. This is dominated by the high population of diabetics in the country and increasing number of funds for management and diabetes care devices market.

The Middle & East Africa (MEA) and Latin America are expected to grow at significant CAGR during forecast period. The increasing diabetic population, rising investment in healthcare industry and rising awareness about disease diagnosis and monitoring are the key factors that drive the growth of global diabetes care devices and drugs market in this region.